MTD
NYSE · Life Sciences Tools & Services
Mettler-Toledo International
$1,753.43
+74.35 (+4.43%)
Financial Highlights (FY 2026)
Revenue
3.91B
Net Income
844.92M
Gross Margin
59.4%
Profit Margin
21.6%
Rev Growth
+0.9%
D/E Ratio
81.23
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 59.4% | 59.4% | 56.0% | 56.0% |
| Operating Margin | 26.0% | 23.4% | 10.4% | 11.5% |
| Profit Margin | 21.6% | 20.5% | 8.1% | 6.9% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 3.91B | 3.88B | 13.50B | 13.55B |
| Gross Profit | 2.32B | 2.30B | 7.56B | 7.59B |
| Operating Income | 1.02B | 909.45M | 1.41B | 1.56B |
| Net Income | 844.92M | 753.65M | 1.09B | 931.82M |
| Gross Margin | 59.4% | 59.4% | 56.0% | 56.0% |
| Operating Margin | 26.0% | 23.4% | 10.4% | 11.5% |
| Profit Margin | 21.6% | 20.5% | 8.1% | 6.9% |
| Rev Growth | +0.9% | +0.9% | +2.4% | +8.1% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 16.62B | 16.62B | 12.19B | 12.25B |
| Total Equity | 204.64M | 204.64M | 20.56B | 19.45B |
| D/E Ratio | 81.23 | 81.23 | 0.59 | 0.63 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 1.09B | 1.03B | 1.78B | 1.90B |
| Free Cash Flow | — | — | 1.19B | 721.40M |